AnaptysBio Inc buy Wells Fargo & Company
Start price
12.12.24
/
50%
€14.40
Target price
12.12.25
€38.17
Performance (%)
159.72%
End price
13.12.25
€37.40
Summary
This prediction ended on 13.12.25 with a price of €37.40. The BUY prediction by Wells_Fargo___Compan for AnaptysBio Inc saw massive gains of 159.72%. Wells_Fargo___Compan has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | 5.115% | 5.115% | 159.189% |
| iShares Core DAX® | -2,68 % | 4,26 % | 2,12 % |
| iShares Nasdaq 100 | 0,73 % | 5,80 % | 34,20 % |
| iShares Nikkei 225® | -0,73 % | 9,32 % | 61,30 % |
| iShares S&P 500 | 1,17 % | 5,48 % | 24,75 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at Wells Fargo & Company from $56.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten